

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative thymic T cell selection (GO:0045060) | 5.17109790 |
| 2 | negative T cell selection (GO:0043383) | 5.13970784 |
| 3 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.99869353 |
| 4 | regulation of gamma-delta T cell activation (GO:0046643) | 4.81118304 |
| 5 | positive T cell selection (GO:0043368) | 4.74224592 |
| 6 | locomotory exploration behavior (GO:0035641) | 4.60838677 |
| 7 | B cell receptor signaling pathway (GO:0050853) | 4.53042890 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.52726793 |
| 9 | positive thymic T cell selection (GO:0045059) | 4.52511131 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.49567507 |
| 11 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.44859229 |
| 12 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.41239767 |
| 13 | response to interleukin-15 (GO:0070672) | 4.37832549 |
| 14 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.36103410 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.30414199 |
| 16 | T cell selection (GO:0045058) | 4.20896388 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.20865146 |
| 18 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.17479641 |
| 19 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.15686553 |
| 20 | thymic T cell selection (GO:0045061) | 4.13769220 |
| 21 | histone H3-K36 demethylation (GO:0070544) | 4.12458509 |
| 22 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.06880433 |
| 23 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.92248888 |
| 24 | synaptic vesicle maturation (GO:0016188) | 3.87717171 |
| 25 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.85785565 |
| 26 | vocalization behavior (GO:0071625) | 3.85411150 |
| 27 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.84968035 |
| 28 | positive regulation of B cell differentiation (GO:0045579) | 3.83788795 |
| 29 | mannose metabolic process (GO:0006013) | 3.74025198 |
| 30 | negative regulation of cell killing (GO:0031342) | 3.68487068 |
| 31 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.68487068 |
| 32 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.68405894 |
| 33 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.65416958 |
| 34 | cellular response to interleukin-15 (GO:0071350) | 3.65134629 |
| 35 | regulation of B cell differentiation (GO:0045577) | 3.60433556 |
| 36 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.57453492 |
| 37 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.55930804 |
| 38 | activated T cell proliferation (GO:0050798) | 3.54967364 |
| 39 | cellular response to ethanol (GO:0071361) | 3.51639023 |
| 40 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.50314073 |
| 41 | histone lysine demethylation (GO:0070076) | 3.41472892 |
| 42 | T cell migration (GO:0072678) | 3.41471438 |
| 43 | glutamate receptor signaling pathway (GO:0007215) | 3.38189807 |
| 44 | sodium ion export (GO:0071436) | 3.36600511 |
| 45 | negative regulation of T cell mediated immunity (GO:0002710) | 3.36154849 |
| 46 | synaptic transmission, glutamatergic (GO:0035249) | 3.35664509 |
| 47 | * positive regulation of granulocyte differentiation (GO:0030854) | 3.35198042 |
| 48 | definitive hemopoiesis (GO:0060216) | 3.34736667 |
| 49 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 3.33809166 |
| 50 | histone H3-K9 demethylation (GO:0033169) | 3.32440296 |
| 51 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.31547568 |
| 52 | cellular potassium ion homeostasis (GO:0030007) | 3.31396273 |
| 53 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.30962657 |
| 54 | Peyers patch development (GO:0048541) | 3.30962657 |
| 55 | histone demethylation (GO:0016577) | 3.29092465 |
| 56 | layer formation in cerebral cortex (GO:0021819) | 3.27737654 |
| 57 | nuclear pore complex assembly (GO:0051292) | 3.26508700 |
| 58 | synaptic vesicle exocytosis (GO:0016079) | 3.23595335 |
| 59 | exploration behavior (GO:0035640) | 3.18676373 |
| 60 | neuron cell-cell adhesion (GO:0007158) | 3.16729646 |
| 61 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.16460336 |
| 62 | protein localization to synapse (GO:0035418) | 3.16383903 |
| 63 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.14990139 |
| 64 | germinal center formation (GO:0002467) | 3.13528037 |
| 65 | glial cell proliferation (GO:0014009) | 3.13428955 |
| 66 | leukocyte aggregation (GO:0070486) | 3.13206855 |
| 67 | synaptic vesicle endocytosis (GO:0048488) | 3.13010505 |
| 68 | prepulse inhibition (GO:0060134) | 3.11321185 |
| 69 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.07272623 |
| 70 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.06137914 |
| 71 | mRNA splice site selection (GO:0006376) | 3.05386933 |
| 72 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.04928383 |
| 73 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.04821513 |
| 74 | establishment of nucleus localization (GO:0040023) | 3.03865590 |
| 75 | cellular extravasation (GO:0045123) | 3.01431745 |
| 76 | dendrite morphogenesis (GO:0048813) | 3.01252879 |
| 77 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.00502266 |
| 78 | response to muramyl dipeptide (GO:0032495) | 2.99741722 |
| 79 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.98962562 |
| 80 | neuron-neuron synaptic transmission (GO:0007270) | 2.98329121 |
| 81 | regulation of synapse structural plasticity (GO:0051823) | 2.97921734 |
| 82 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.97592799 |
| 83 | dendritic spine morphogenesis (GO:0060997) | 2.97322343 |
| 84 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.96946679 |
| 85 | * histone H3-K4 trimethylation (GO:0080182) | 2.96373708 |
| 86 | positive regulation of Rap GTPase activity (GO:0032854) | 2.96233696 |
| 87 | long-term memory (GO:0007616) | 2.95475808 |
| 88 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.92761785 |
| 89 | neurotransmitter secretion (GO:0007269) | 2.92073414 |
| 90 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.91036411 |
| 91 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.90251068 |
| 92 | positive regulation of synapse maturation (GO:0090129) | 2.87494346 |
| 93 | regulation of necroptotic process (GO:0060544) | 2.86156107 |
| 94 | gamma-aminobutyric acid transport (GO:0015812) | 2.85846886 |
| 95 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.85135785 |
| 96 | T cell homeostasis (GO:0043029) | 2.84846246 |
| 97 | protein dealkylation (GO:0008214) | 2.84817863 |
| 98 | protein demethylation (GO:0006482) | 2.84817863 |
| 99 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.84601159 |
| 100 | glutamate secretion (GO:0014047) | 2.82672646 |
| 101 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.82415813 |
| 102 | auditory behavior (GO:0031223) | 2.81124476 |
| 103 | regulation of postsynaptic membrane potential (GO:0060078) | 2.80574995 |
| 104 | phospholipid scrambling (GO:0017121) | 2.79638859 |
| 105 | axonal fasciculation (GO:0007413) | 2.78545301 |
| 106 | dosage compensation (GO:0007549) | 2.78268106 |
| 107 | natural killer cell differentiation (GO:0001779) | 2.77912675 |
| 108 | postsynaptic membrane organization (GO:0001941) | 2.77817993 |
| 109 | histone H3-K9 modification (GO:0061647) | 2.77481606 |
| 110 | B cell homeostasis (GO:0001782) | 2.77258200 |
| 111 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.75672248 |
| 112 | nuclear pore organization (GO:0006999) | 2.75634129 |
| 113 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.75398654 |
| 114 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.75398654 |
| 115 | detection of other organism (GO:0098543) | 2.75323497 |
| 116 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.75295500 |
| 117 | presynaptic membrane assembly (GO:0097105) | 2.74570192 |
| 118 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.72621486 |
| 119 | detection of bacterium (GO:0016045) | 2.72034982 |
| 120 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.70990462 |
| 121 | * regulation of histone H3-K27 methylation (GO:0061085) | 2.70903104 |
| 122 | regulation of regulatory T cell differentiation (GO:0045589) | 2.70678350 |
| 123 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.68740668 |
| 124 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.68177391 |
| 125 | interkinetic nuclear migration (GO:0022027) | 2.67856136 |
| 126 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.66808213 |
| 127 | necrotic cell death (GO:0070265) | 2.66389542 |
| 128 | cerebellar granule cell differentiation (GO:0021707) | 2.66219086 |
| 129 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.65804116 |
| 130 | potassium ion import (GO:0010107) | 2.65490417 |
| 131 | megakaryocyte development (GO:0035855) | 2.65323378 |
| 132 | long-term synaptic potentiation (GO:0060291) | 2.65094585 |
| 133 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.64968690 |
| 134 | response to auditory stimulus (GO:0010996) | 2.63651482 |
| 135 | regulation of ARF protein signal transduction (GO:0032012) | 2.62689138 |
| 136 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.62507863 |
| 137 | membrane hyperpolarization (GO:0060081) | 2.62491893 |
| 138 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.62326708 |
| 139 | hepatocyte apoptotic process (GO:0097284) | 2.62254172 |
| 140 | L-amino acid import (GO:0043092) | 2.62113639 |
| 141 | positive regulation by symbiont of host defense response (GO:0052509) | 2.61873552 |
| 142 | modulation by symbiont of host defense response (GO:0052031) | 2.61873552 |
| 143 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.61873552 |
| 144 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.61873552 |
| 145 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.61873552 |
| 146 | modulation by symbiont of host immune response (GO:0052553) | 2.61873552 |
| 147 | regulation of synaptic vesicle transport (GO:1902803) | 2.61847662 |
| 148 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.61591804 |
| 149 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.61591804 |
| 150 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.61591804 |
| 151 | membrane depolarization during action potential (GO:0086010) | 2.61546197 |
| 152 | regulation of RNA export from nucleus (GO:0046831) | 2.61099262 |
| 153 | T cell receptor signaling pathway (GO:0050852) | 2.59601291 |
| 154 | response to histamine (GO:0034776) | 2.59293731 |
| 155 | striatum development (GO:0021756) | 2.58276581 |
| 156 | interferon-gamma production (GO:0032609) | 2.57934424 |
| 157 | cell differentiation in hindbrain (GO:0021533) | 2.57607006 |
| 158 | regulation of Rap GTPase activity (GO:0032317) | 2.57283536 |
| 159 | mechanosensory behavior (GO:0007638) | 2.56685677 |
| 160 | histone deubiquitination (GO:0016578) | 2.56496292 |
| 161 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.54976534 |
| 162 | negative regulation of B cell proliferation (GO:0030889) | 2.54833846 |
| 163 | innervation (GO:0060384) | 2.54789514 |
| 164 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.53938653 |
| 165 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.53839930 |
| 166 | negative regulation of adaptive immune response (GO:0002820) | 2.52672408 |
| 167 | positive regulation of tolerance induction (GO:0002645) | 2.52124523 |
| 168 | * histone H3-K4 methylation (GO:0051568) | 2.51214955 |
| 169 | neuronal ion channel clustering (GO:0045161) | 2.50695219 |
| 170 | positive regulation of membrane potential (GO:0045838) | 2.49483411 |
| 171 | neuromuscular process controlling balance (GO:0050885) | 2.48017980 |
| 172 | neuronal action potential propagation (GO:0019227) | 2.47500581 |
| 173 | visual learning (GO:0008542) | 2.47469073 |
| 174 | transmission of nerve impulse (GO:0019226) | 2.47199424 |
| 175 | cellular sodium ion homeostasis (GO:0006883) | 2.46852667 |
| 176 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.46347476 |
| 177 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.46321976 |
| 178 | behavioral defense response (GO:0002209) | 2.46145517 |
| 179 | behavioral fear response (GO:0001662) | 2.46145517 |
| 180 | cell communication by electrical coupling (GO:0010644) | 2.45709904 |
| 181 | neuron recognition (GO:0008038) | 2.45161626 |
| 182 | regulation of respiratory system process (GO:0044065) | 2.44722389 |
| 183 | presynaptic membrane organization (GO:0097090) | 2.44298694 |
| 184 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.44208144 |
| 185 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.40657203 |
| 186 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.40371204 |
| 187 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.40027456 |
| 188 | membrane depolarization (GO:0051899) | 2.39444317 |
| 189 | clathrin coat assembly (GO:0048268) | 2.38830101 |
| 190 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.37162945 |
| 191 | regulation of synaptic plasticity (GO:0048167) | 2.35705568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.63190601 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.20741830 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.96321520 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.99391778 |
| 5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.98134765 |
| 6 | MYB_26560356_Chip-Seq_TH2_Human | 2.85126514 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.83465667 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.82222418 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.74194706 |
| 10 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.67048745 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.57324043 |
| 12 | MYB_26560356_Chip-Seq_TH1_Human | 2.51564688 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46345339 |
| 14 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.46150053 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.42840233 |
| 16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.42452345 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.40181352 |
| 18 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.31552617 |
| 19 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.25333226 |
| 20 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.25091955 |
| 21 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.24991834 |
| 22 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.22539731 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.17018628 |
| 24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.13051237 |
| 25 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.11922366 |
| 26 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.11922366 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.11642400 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 2.11120267 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.05510456 |
| 30 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.05230365 |
| 31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.04123649 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.03790599 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.02909261 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.97736676 |
| 35 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.95616048 |
| 36 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.89456575 |
| 37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.88342280 |
| 38 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.87857445 |
| 39 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.86412554 |
| 40 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.86193237 |
| 41 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.81849182 |
| 42 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.80545122 |
| 43 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.80475731 |
| 44 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.80153951 |
| 45 | SPI1_23127762_ChIP-Seq_K562_Human | 1.79028227 |
| 46 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.76937803 |
| 47 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.73675164 |
| 48 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.72581366 |
| 49 | UTX_26944678_Chip-Seq_JUKART_Human | 1.72287083 |
| 50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.72174647 |
| 51 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.67456344 |
| 52 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.65288263 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.64382298 |
| 54 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.62265952 |
| 55 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.60738583 |
| 56 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.60187788 |
| 57 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.59343407 |
| 58 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.59166190 |
| 59 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.58544105 |
| 60 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.56336575 |
| 61 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.54018280 |
| 62 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.53235645 |
| 63 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.52966261 |
| 64 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.51152993 |
| 65 | TP53_16413492_ChIP-PET_HCT116_Human | 1.50810493 |
| 66 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.50238894 |
| 67 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.49953560 |
| 68 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.48655883 |
| 69 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.48145815 |
| 70 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.47092933 |
| 71 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.46159634 |
| 72 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.44407684 |
| 73 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.43610902 |
| 74 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.43396155 |
| 75 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.42731673 |
| 76 | MAF_26560356_Chip-Seq_TH2_Human | 1.39855994 |
| 77 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.39356304 |
| 78 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.34916860 |
| 79 | AR_19668381_ChIP-Seq_PC3_Human | 1.34750389 |
| 80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34548655 |
| 81 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.33819572 |
| 82 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.33794243 |
| 83 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.31311770 |
| 84 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.29669058 |
| 85 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.29592898 |
| 86 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.28969262 |
| 87 | GATA1_19941826_ChIP-Seq_K562_Human | 1.28275579 |
| 88 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.28133071 |
| 89 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.27833993 |
| 90 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.27781470 |
| 91 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26520727 |
| 92 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.25223446 |
| 93 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.25215209 |
| 94 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.24920419 |
| 95 | STAT3_23295773_ChIP-Seq_U87_Human | 1.24479002 |
| 96 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.24147556 |
| 97 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.24008005 |
| 98 | GATA2_19941826_ChIP-Seq_K562_Human | 1.23885552 |
| 99 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.23611945 |
| 100 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23202875 |
| 101 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22901057 |
| 102 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.22901057 |
| 103 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.22303976 |
| 104 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.22276614 |
| 105 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.21692407 |
| 106 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.20101796 |
| 107 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18895787 |
| 108 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.18859994 |
| 109 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.17970878 |
| 110 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.17961675 |
| 111 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.16718281 |
| 112 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15932584 |
| 113 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.15603715 |
| 114 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.14636042 |
| 115 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14290406 |
| 116 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.13993903 |
| 117 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12318523 |
| 118 | KDM2B_26808549_Chip-Seq_K562_Human | 1.11335184 |
| 119 | TCF4_23295773_ChIP-Seq_U87_Human | 1.10577624 |
| 120 | FUS_26573619_Chip-Seq_HEK293_Human | 1.10320829 |
| 121 | AR_25329375_ChIP-Seq_VCAP_Human | 1.09563539 |
| 122 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09248252 |
| 123 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08796001 |
| 124 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.08698283 |
| 125 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.08202681 |
| 126 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.08150677 |
| 127 | P300_19829295_ChIP-Seq_ESCs_Human | 1.08032988 |
| 128 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.07153411 |
| 129 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.06164614 |
| 130 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.06157497 |
| 131 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.05876973 |
| 132 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05643693 |
| 133 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.04631675 |
| 134 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03360684 |
| 135 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03267261 |
| 136 | RXR_22108803_ChIP-Seq_LS180_Human | 1.03152074 |
| 137 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.02911506 |
| 138 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.02623495 |
| 139 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02610334 |
| 140 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02516453 |
| 141 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02397371 |
| 142 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.99671711 |
| 143 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98285259 |
| 144 | MYC_22102868_ChIP-Seq_BL_Human | 0.97899136 |
| 145 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97506963 |
| 146 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.97152046 |
| 147 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97096178 |
| 148 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96150897 |
| 149 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.95842697 |
| 150 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.95411849 |
| 151 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95073033 |
| 152 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.94995613 |
| 153 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.91665168 |
| 154 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91444225 |
| 155 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89104655 |
| 156 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88899328 |
| 157 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.88326946 |
| 158 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86210502 |
| 159 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.85772916 |
| 160 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81195085 |
| 161 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.78652674 |
| 162 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78287922 |
| 163 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.77521621 |
| 164 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76347746 |
| 165 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.75073822 |
| 166 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.74941823 |
| 167 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.74694662 |
| 168 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.74228816 |
| 169 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.73899718 |
| 170 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.73185563 |
| 171 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.73169231 |
| 172 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.73162251 |
| 173 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.72396127 |
| 174 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.72008391 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.56497392 |
| 2 | MP0000569_abnormal_digit_pigmentation | 4.72909532 |
| 3 | MP0002009_preneoplasia | 4.16102042 |
| 4 | MP0008057_abnormal_DNA_replication | 4.09709384 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.41675389 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.36227493 |
| 7 | MP0003787_abnormal_imprinting | 3.23481447 |
| 8 | MP0003880_abnormal_central_pattern | 2.96864462 |
| 9 | MP0001800_abnormal_humoral_immune | 2.73926601 |
| 10 | MP0009745_abnormal_behavioral_response | 2.71284351 |
| 11 | MP0002063_abnormal_learning/memory/cond | 2.63494892 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.56047746 |
| 13 | MP0003436_decreased_susceptibility_to | 2.54768143 |
| 14 | MP0001486_abnormal_startle_reflex | 2.39698872 |
| 15 | MP0002064_seizures | 2.38859968 |
| 16 | MP0009046_muscle_twitch | 2.34630884 |
| 17 | MP0008569_lethality_at_weaning | 2.33876564 |
| 18 | MP0000685_abnormal_immune_system | 2.29043811 |
| 19 | MP0002572_abnormal_emotion/affect_behav | 2.28118190 |
| 20 | MP0002822_catalepsy | 2.24940921 |
| 21 | * MP0000703_abnormal_thymus_morphology | 2.22794218 |
| 22 | * MP0002398_abnormal_bone_marrow | 2.19079883 |
| 23 | MP0004270_analgesia | 2.17585105 |
| 24 | MP0004885_abnormal_endolymph | 2.10013762 |
| 25 | MP0005000_abnormal_immune_tolerance | 2.09686607 |
| 26 | MP0005671_abnormal_response_to | 2.08035706 |
| 27 | MP0001790_abnormal_immune_system | 2.05057709 |
| 28 | MP0005387_immune_system_phenotype | 2.05057709 |
| 29 | MP0002006_tumorigenesis | 2.04463742 |
| 30 | * MP0002420_abnormal_adaptive_immunity | 2.03815564 |
| 31 | MP0002723_abnormal_immune_serum | 2.00692266 |
| 32 | * MP0001819_abnormal_immune_cell | 1.99489610 |
| 33 | MP0004381_abnormal_hair_follicle | 1.99089789 |
| 34 | MP0000778_abnormal_nervous_system | 1.98683041 |
| 35 | MP0002452_abnormal_antigen_presenting | 1.88225100 |
| 36 | MP0002405_respiratory_system_inflammati | 1.83287084 |
| 37 | * MP0000716_abnormal_immune_system | 1.81902479 |
| 38 | MP0002272_abnormal_nervous_system | 1.80748565 |
| 39 | MP0003724_increased_susceptibility_to | 1.79360122 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.78836609 |
| 41 | MP0002722_abnormal_immune_system | 1.78422982 |
| 42 | MP0002067_abnormal_sensory_capabilities | 1.73169629 |
| 43 | MP0003303_peritoneal_inflammation | 1.69293109 |
| 44 | MP0002419_abnormal_innate_immunity | 1.66295525 |
| 45 | MP0005025_abnormal_response_to | 1.65958118 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.65817907 |
| 47 | MP0001501_abnormal_sleep_pattern | 1.65785024 |
| 48 | MP0005451_abnormal_body_composition | 1.64681428 |
| 49 | MP0005174_abnormal_tail_pigmentation | 1.63032085 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 1.62457982 |
| 51 | MP0001968_abnormal_touch/_nociception | 1.61581247 |
| 52 | MP0005646_abnormal_pituitary_gland | 1.61478420 |
| 53 | MP0009780_abnormal_chondrocyte_physiolo | 1.61256293 |
| 54 | MP0002557_abnormal_social/conspecific_i | 1.61144514 |
| 55 | MP0001502_abnormal_circadian_rhythm | 1.55341511 |
| 56 | MP0005409_darkened_coat_color | 1.52947637 |
| 57 | MP0002184_abnormal_innervation | 1.51099407 |
| 58 | MP0004947_skin_inflammation | 1.48615080 |
| 59 | * MP0002429_abnormal_blood_cell | 1.47432088 |
| 60 | MP0008961_abnormal_basal_metabolism | 1.46841409 |
| 61 | MP0005310_abnormal_salivary_gland | 1.46263754 |
| 62 | MP0004924_abnormal_behavior | 1.46034972 |
| 63 | MP0005386_behavior/neurological_phenoty | 1.46034972 |
| 64 | MP0003121_genomic_imprinting | 1.44068997 |
| 65 | MP0005076_abnormal_cell_differentiation | 1.42530742 |
| 66 | MP0004811_abnormal_neuron_physiology | 1.41321913 |
| 67 | MP0001851_eye_inflammation | 1.35962947 |
| 68 | MP0003828_pulmonary_edema | 1.31953247 |
| 69 | MP0000955_abnormal_spinal_cord | 1.31876758 |
| 70 | MP0001440_abnormal_grooming_behavior | 1.29200900 |
| 71 | MP0001984_abnormal_olfaction | 1.28237233 |
| 72 | MP0009333_abnormal_splenocyte_physiolog | 1.28179081 |
| 73 | MP0002734_abnormal_mechanical_nocicepti | 1.27202897 |
| 74 | MP0002882_abnormal_neuron_morphology | 1.24838664 |
| 75 | MP0003091_abnormal_cell_migration | 1.24562867 |
| 76 | MP0002152_abnormal_brain_morphology | 1.19061214 |
| 77 | MP0005397_hematopoietic_system_phenotyp | 1.18931490 |
| 78 | MP0001545_abnormal_hematopoietic_system | 1.18931490 |
| 79 | MP0010352_gastrointestinal_tract_polyps | 1.17452969 |
| 80 | MP0003172_abnormal_lysosome_physiology | 1.17113311 |
| 81 | MP0003122_maternal_imprinting | 1.16541040 |
| 82 | MP0001188_hyperpigmentation | 1.15104565 |
| 83 | MP0004264_abnormal_extraembryonic_tissu | 1.14334955 |
| 84 | MP0005464_abnormal_platelet_physiology | 1.13455735 |
| 85 | MP0002909_abnormal_adrenal_gland | 1.13162231 |
| 86 | MP0005394_taste/olfaction_phenotype | 1.12709481 |
| 87 | MP0005499_abnormal_olfactory_system | 1.12709481 |
| 88 | MP0005075_abnormal_melanosome_morpholog | 1.12390982 |
| 89 | MP0001845_abnormal_inflammatory_respons | 1.08633870 |
| 90 | MP0002735_abnormal_chemical_nociception | 1.08556339 |
| 91 | MP0004858_abnormal_nervous_system | 1.08503744 |
| 92 | MP0003633_abnormal_nervous_system | 1.07924227 |
| 93 | MP0010234_abnormal_vibrissa_follicle | 1.07325506 |
| 94 | MP0009785_altered_susceptibility_to | 1.07315123 |
| 95 | MP0002933_joint_inflammation | 1.07161113 |
| 96 | MP0008260_abnormal_autophagy | 1.06963335 |
| 97 | MP0002089_abnormal_postnatal_growth/wei | 1.04613940 |
| 98 | MP0005551_abnormal_eye_electrophysiolog | 1.00353251 |
| 99 | MP0004808_abnormal_hematopoietic_stem | 0.99240439 |
| 100 | MP0002736_abnormal_nociception_after | 0.98148413 |
| 101 | MP0003045_fibrosis | 0.97023549 |
| 102 | MP0001970_abnormal_pain_threshold | 0.95893871 |
| 103 | MP0000631_abnormal_neuroendocrine_gland | 0.95861318 |
| 104 | * MP0002066_abnormal_motor_capabilities/c | 0.95427969 |
| 105 | MP0001853_heart_inflammation | 0.95101824 |
| 106 | MP0002733_abnormal_thermal_nociception | 0.93585036 |
| 107 | MP0003183_abnormal_peptide_metabolism | 0.92316096 |
| 108 | MP0006072_abnormal_retinal_apoptosis | 0.92043634 |
| 109 | MP0005187_abnormal_penis_morphology | 0.91258497 |
| 110 | MP0002019_abnormal_tumor_incidence | 0.90752651 |
| 111 | MP0009115_abnormal_fat_cell | 0.89720960 |
| 112 | MP0010307_abnormal_tumor_latency | 0.88899074 |
| 113 | MP0008995_early_reproductive_senescence | 0.88654035 |
| 114 | MP0003879_abnormal_hair_cell | 0.87555946 |
| 115 | MP0003861_abnormal_nervous_system | 0.87087612 |
| 116 | MP0009278_abnormal_bone_marrow | 0.86941026 |
| 117 | MP0003631_nervous_system_phenotype | 0.86648973 |
| 118 | MP0005220_abnormal_exocrine_pancreas | 0.85903971 |
| 119 | MP0003763_abnormal_thymus_physiology | 0.85788899 |
| 120 | MP0006292_abnormal_olfactory_placode | 0.85082438 |
| 121 | MP0004883_abnormal_blood_vessel | 0.84839118 |
| 122 | MP0002396_abnormal_hematopoietic_system | 0.84571572 |
| 123 | MP0005621_abnormal_cell_physiology | 0.84465912 |
| 124 | MP0001177_atelectasis | 0.83825806 |
| 125 | MP0003300_gastrointestinal_ulcer | 0.82682955 |
| 126 | MP0002998_abnormal_bone_remodeling | 0.82202185 |
| 127 | MP0000465_gastrointestinal_hemorrhage | 0.80738982 |
| 128 | MP0004185_abnormal_adipocyte_glucose | 0.80005893 |
| 129 | MP0010678_abnormal_skin_adnexa | 0.79813029 |
| 130 | MP0004484_altered_response_of | 0.78635831 |
| 131 | MP0002132_abnormal_respiratory_system | 0.78379355 |
| 132 | MP0005666_abnormal_adipose_tissue | 0.78118237 |
| 133 | MP0003632_abnormal_nervous_system | 0.76968680 |
| 134 | MP0006082_CNS_inflammation | 0.76143342 |
| 135 | MP0000015_abnormal_ear_pigmentation | 0.75328495 |
| 136 | MP0004130_abnormal_muscle_cell | 0.75297116 |
| 137 | MP0001299_abnormal_eye_distance/ | 0.75081429 |
| 138 | MP0001873_stomach_inflammation | 0.74726219 |
| 139 | MP0001533_abnormal_skeleton_physiology | 0.74448425 |
| 140 | MP0000751_myopathy | 0.74386921 |
| 141 | MP0004142_abnormal_muscle_tone | 0.74316218 |
| 142 | MP0002166_altered_tumor_susceptibility | 0.74214801 |
| 143 | MP0003943_abnormal_hepatobiliary_system | 0.72996622 |
| 144 | MP0003115_abnormal_respiratory_system | 0.72398171 |
| 145 | MP0002095_abnormal_skin_pigmentation | 0.72343414 |
| 146 | MP0003634_abnormal_glial_cell | 0.72209806 |
| 147 | MP0005645_abnormal_hypothalamus_physiol | 0.71736728 |
| 148 | MP0003690_abnormal_glial_cell | 0.71711568 |
| 149 | MP0000858_altered_metastatic_potential | 0.71304898 |
| 150 | MP0003221_abnormal_cardiomyocyte_apopto | 0.71301439 |
| 151 | MP0003283_abnormal_digestive_organ | 0.70999407 |
| 152 | * MP0010769_abnormal_survival | 0.70829163 |
| 153 | MP0001915_intracranial_hemorrhage | 0.69676486 |
| 154 | MP0000428_abnormal_craniofacial_morphol | 0.68755637 |
| 155 | MP0004742_abnormal_vestibular_system | 0.68478180 |
| 156 | * MP0010770_preweaning_lethality | 0.67245655 |
| 157 | * MP0002082_postnatal_lethality | 0.67245655 |
| 158 | * MP0010768_mortality/aging | 0.66727058 |
| 159 | MP0001943_abnormal_respiration | 0.66661731 |
| 160 | MP0005375_adipose_tissue_phenotype | 0.66630507 |
| 161 | MP0002693_abnormal_pancreas_physiology | 0.66619896 |
| 162 | MP0004215_abnormal_myocardial_fiber | 0.66576051 |
| 163 | MP0002086_abnormal_extraembryonic_tissu | 0.66509252 |
| 164 | MP0001270_distended_abdomen | 0.64884126 |
| 165 | MP0002229_neurodegeneration | 0.63108145 |
| 166 | MP0003935_abnormal_craniofacial_develop | 0.63092801 |
| 167 | MP0002168_other_aberrant_phenotype | 0.62693713 |
| 168 | MP0003866_abnormal_defecation | 0.62610048 |
| 169 | MP0003984_embryonic_growth_retardation | 0.62369081 |
| 170 | MP0000371_diluted_coat_color | 0.62177490 |
| 171 | MP0000383_abnormal_hair_follicle | 0.62028715 |
| 172 | MP0004145_abnormal_muscle_electrophysio | 0.61965935 |
| 173 | MP0002088_abnormal_embryonic_growth/wei | 0.61190915 |
| 174 | MP0001348_abnormal_lacrimal_gland | 0.60171476 |
| 175 | MP0000003_abnormal_adipose_tissue | 0.59602233 |
| 176 | MP0008469_abnormal_protein_level | 0.59146399 |
| 177 | MP0006054_spinal_hemorrhage | 0.57461858 |
| 178 | MP0002925_abnormal_cardiovascular_devel | 0.55921129 |
| 179 | * MP0000350_abnormal_cell_proliferation | 0.55281502 |
| 180 | MP0002970_abnormal_white_adipose | 0.55076792 |
| 181 | MP0001784_abnormal_fluid_regulation | 0.53147224 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 4.03329160 |
| 2 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.99244515 |
| 3 | Eczematoid dermatitis (HP:0000976) | 3.78948499 |
| 4 | Abnormality of T cell number (HP:0011839) | 3.70650679 |
| 5 | Focal motor seizures (HP:0011153) | 3.66101954 |
| 6 | Recurrent viral infections (HP:0004429) | 3.51424595 |
| 7 | Colitis (HP:0002583) | 3.50543322 |
| 8 | Recurrent fungal infections (HP:0002841) | 3.38744569 |
| 9 | Focal seizures (HP:0007359) | 3.27550630 |
| 10 | Macroorchidism (HP:0000053) | 3.21604381 |
| 11 | Febrile seizures (HP:0002373) | 3.20085482 |
| 12 | Recurrent cutaneous fungal infections (HP:0011370) | 3.10377293 |
| 13 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.10377293 |
| 14 | Epileptic encephalopathy (HP:0200134) | 3.07708940 |
| 15 | Viral hepatitis (HP:0006562) | 3.05959719 |
| 16 | Papilledema (HP:0001085) | 3.05315920 |
| 17 | Abnormality of the fingertips (HP:0001211) | 3.03639320 |
| 18 | Broad-based gait (HP:0002136) | 3.01178872 |
| 19 | Progressive cerebellar ataxia (HP:0002073) | 3.00247470 |
| 20 | Recurrent bacterial skin infections (HP:0005406) | 2.95697175 |
| 21 | Gastrointestinal infarctions (HP:0005244) | 2.95149980 |
| 22 | Abnormality of T cells (HP:0002843) | 2.93833356 |
| 23 | Inflammation of the large intestine (HP:0002037) | 2.90741067 |
| 24 | Agammaglobulinemia (HP:0004432) | 2.87811415 |
| 25 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.85653442 |
| 26 | Gastrointestinal inflammation (HP:0004386) | 2.83823612 |
| 27 | Subacute progressive viral hepatitis (HP:0006572) | 2.82062879 |
| 28 | Narrow palate (HP:0000189) | 2.78144274 |
| 29 | Meningitis (HP:0001287) | 2.74230030 |
| 30 | Chronic diarrhea (HP:0002028) | 2.68639038 |
| 31 | Recurrent abscess formation (HP:0002722) | 2.67997946 |
| 32 | Gaze-evoked nystagmus (HP:0000640) | 2.67359353 |
| 33 | Spontaneous hematomas (HP:0007420) | 2.66922194 |
| 34 | Autoimmune hemolytic anemia (HP:0001890) | 2.66827693 |
| 35 | Truncal ataxia (HP:0002078) | 2.65412560 |
| 36 | Pustule (HP:0200039) | 2.61779408 |
| 37 | Genetic anticipation (HP:0003743) | 2.61175707 |
| 38 | Myositis (HP:0100614) | 2.61099368 |
| 39 | Severe combined immunodeficiency (HP:0004430) | 2.58452284 |
| 40 | Acute myeloid leukemia (HP:0004808) | 2.55459031 |
| 41 | Obsessive-compulsive behavior (HP:0000722) | 2.55194630 |
| 42 | Granulocytopenia (HP:0001913) | 2.49496939 |
| 43 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.46424759 |
| 44 | Impaired smooth pursuit (HP:0007772) | 2.44642073 |
| 45 | Short 4th metacarpal (HP:0010044) | 2.43158435 |
| 46 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.43158435 |
| 47 | Abnormality of T cell physiology (HP:0011840) | 2.42410334 |
| 48 | Vasculitis (HP:0002633) | 2.41583383 |
| 49 | Basal cell carcinoma (HP:0002671) | 2.40991123 |
| 50 | Hyperacusis (HP:0010780) | 2.40894942 |
| 51 | Recurrent skin infections (HP:0001581) | 2.40883465 |
| 52 | Hemiplegia (HP:0002301) | 2.40763779 |
| 53 | Increased IgE level (HP:0003212) | 2.38269448 |
| 54 | Chest pain (HP:0100749) | 2.36277022 |
| 55 | Slow saccadic eye movements (HP:0000514) | 2.33338059 |
| 56 | Protruding tongue (HP:0010808) | 2.33275481 |
| 57 | Action tremor (HP:0002345) | 2.33098558 |
| 58 | Trigonocephaly (HP:0000243) | 2.32748243 |
| 59 | Pointed chin (HP:0000307) | 2.32535649 |
| 60 | Dysmetric saccades (HP:0000641) | 2.32074796 |
| 61 | Volvulus (HP:0002580) | 2.32025027 |
| 62 | Lymphopenia (HP:0001888) | 2.31366853 |
| 63 | Recurrent bronchitis (HP:0002837) | 2.31307725 |
| 64 | Fatigue (HP:0012378) | 2.31183211 |
| 65 | Prolonged bleeding time (HP:0003010) | 2.30580592 |
| 66 | Heterotopia (HP:0002282) | 2.29600646 |
| 67 | Encephalitis (HP:0002383) | 2.28744839 |
| 68 | Myokymia (HP:0002411) | 2.28476675 |
| 69 | Stereotypic behavior (HP:0000733) | 2.28178988 |
| 70 | Impaired social interactions (HP:0000735) | 2.27547728 |
| 71 | Abnormal social behavior (HP:0012433) | 2.27547728 |
| 72 | Mediastinal lymphadenopathy (HP:0100721) | 2.25316423 |
| 73 | Optic neuritis (HP:0100653) | 2.25082433 |
| 74 | Retrobulbar optic neuritis (HP:0100654) | 2.25082433 |
| 75 | Sandal gap (HP:0001852) | 2.24775437 |
| 76 | Hypoplasia of the thymus (HP:0000778) | 2.24379090 |
| 77 | Scanning speech (HP:0002168) | 2.23671227 |
| 78 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.23142935 |
| 79 | Absent frontal sinuses (HP:0002688) | 2.22739438 |
| 80 | Cellulitis (HP:0100658) | 2.21770848 |
| 81 | Dislocated radial head (HP:0003083) | 2.21436797 |
| 82 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.20431009 |
| 83 | Acute lymphatic leukemia (HP:0006721) | 2.19689648 |
| 84 | Gingivitis (HP:0000230) | 2.18832034 |
| 85 | Elfin facies (HP:0004428) | 2.16932281 |
| 86 | Drooling (HP:0002307) | 2.15305772 |
| 87 | Excessive salivation (HP:0003781) | 2.15305772 |
| 88 | Postural instability (HP:0002172) | 2.15030658 |
| 89 | Neoplasm of the heart (HP:0100544) | 2.14149369 |
| 90 | Visual hallucinations (HP:0002367) | 2.13951411 |
| 91 | Poor eye contact (HP:0000817) | 2.12577959 |
| 92 | Abnormality of binocular vision (HP:0011514) | 2.12003248 |
| 93 | Diplopia (HP:0000651) | 2.12003248 |
| 94 | Orchitis (HP:0100796) | 2.11043421 |
| 95 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.08325070 |
| 96 | Prominent nose (HP:0000448) | 2.08042532 |
| 97 | Tented upper lip vermilion (HP:0010804) | 2.07427390 |
| 98 | Arterial thrombosis (HP:0004420) | 2.06968784 |
| 99 | Panhypogammaglobulinemia (HP:0003139) | 2.04729564 |
| 100 | Depressed nasal tip (HP:0000437) | 2.01676382 |
| 101 | Osteomyelitis (HP:0002754) | 2.01333595 |
| 102 | Submucous cleft hard palate (HP:0000176) | 2.00851293 |
| 103 | Verrucae (HP:0200043) | 2.00399289 |
| 104 | Papilloma (HP:0012740) | 2.00399289 |
| 105 | Leukocytosis (HP:0001974) | 1.99440360 |
| 106 | Urinary urgency (HP:0000012) | 1.99434857 |
| 107 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.96333290 |
| 108 | Abnormality of the radial head (HP:0003995) | 1.95984981 |
| 109 | Hepatitis (HP:0012115) | 1.95931246 |
| 110 | Aqueductal stenosis (HP:0002410) | 1.95262640 |
| 111 | Combined immunodeficiency (HP:0005387) | 1.95101880 |
| 112 | Spinal cord lesions (HP:0100561) | 1.93931666 |
| 113 | Syringomyelia (HP:0003396) | 1.93931666 |
| 114 | Dysdiadochokinesis (HP:0002075) | 1.93884801 |
| 115 | Broad face (HP:0000283) | 1.93175919 |
| 116 | Eosinophilia (HP:0001880) | 1.92657752 |
| 117 | Pulmonary infiltrates (HP:0002113) | 1.92400707 |
| 118 | Atonic seizures (HP:0010819) | 1.91493002 |
| 119 | Stomatitis (HP:0010280) | 1.89494335 |
| 120 | Neonatal hypoglycemia (HP:0001998) | 1.87424219 |
| 121 | Broad metatarsal (HP:0001783) | 1.87200998 |
| 122 | Abnormal hair whorl (HP:0010721) | 1.86859235 |
| 123 | Epistaxis (HP:0000421) | 1.86613761 |
| 124 | Depression (HP:0000716) | 1.86098636 |
| 125 | Inappropriate behavior (HP:0000719) | 1.86032732 |
| 126 | IgM deficiency (HP:0002850) | 1.85575582 |
| 127 | Gingival bleeding (HP:0000225) | 1.85177728 |
| 128 | Aplasia involving bones of the extremities (HP:0009825) | 1.84578249 |
| 129 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.84578249 |
| 130 | Aplasia of the phalanges of the hand (HP:0009802) | 1.84578249 |
| 131 | Truncal obesity (HP:0001956) | 1.83633813 |
| 132 | Hematochezia (HP:0002573) | 1.83549470 |
| 133 | Abnormality of the astrocytes (HP:0100707) | 1.83096125 |
| 134 | Astrocytoma (HP:0009592) | 1.83096125 |
| 135 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.82804451 |
| 136 | Abnormality of oral frenula (HP:0000190) | 1.82445213 |
| 137 | Abnormality of eosinophils (HP:0001879) | 1.78338053 |
| 138 | Somatic mutation (HP:0001428) | 1.78188304 |
| 139 | IgA deficiency (HP:0002720) | 1.77275380 |
| 140 | Abnormality of the peritoneum (HP:0002585) | 1.77259171 |
| 141 | Absence seizures (HP:0002121) | 1.76867313 |
| 142 | Insomnia (HP:0100785) | 1.76862184 |
| 143 | 2-3 toe syndactyly (HP:0004691) | 1.76710995 |
| 144 | Papillary thyroid carcinoma (HP:0002895) | 1.75473930 |
| 145 | Widely spaced teeth (HP:0000687) | 1.75347065 |
| 146 | Hemoptysis (HP:0002105) | 1.75073261 |
| 147 | Pulmonary embolism (HP:0002204) | 1.74954620 |
| 148 | Ankle clonus (HP:0011448) | 1.74764681 |
| 149 | Hemiparesis (HP:0001269) | 1.74657347 |
| 150 | Deeply set eye (HP:0000490) | 1.74347944 |
| 151 | Thyroiditis (HP:0100646) | 1.73836597 |
| 152 | Testicular neoplasm (HP:0010788) | 1.73801158 |
| 153 | Anteriorly placed anus (HP:0001545) | 1.73199423 |
| 154 | Ependymoma (HP:0002888) | 1.73159562 |
| 155 | Supranuclear gaze palsy (HP:0000605) | 1.72581123 |
| 156 | Tapered finger (HP:0001182) | 1.72356566 |
| 157 | Open mouth (HP:0000194) | 1.71761069 |
| 158 | Alveolar cell carcinoma (HP:0006519) | 1.71738073 |
| 159 | Abnormality of the 4th metacarpal (HP:0010012) | 1.71468470 |
| 160 | Midline defect of the nose (HP:0004122) | 1.70580979 |
| 161 | Keratoconjunctivitis sicca (HP:0001097) | 1.70520670 |
| 162 | Long eyelashes (HP:0000527) | 1.69815065 |
| 163 | Anal stenosis (HP:0002025) | 1.69533308 |
| 164 | Coarse hair (HP:0002208) | 1.68946943 |
| 165 | Ankyloglossia (HP:0010296) | 1.68619454 |
| 166 | Megalencephaly (HP:0001355) | 1.68559706 |
| 167 | Overriding aorta (HP:0002623) | 1.68136218 |
| 168 | Acute hepatic failure (HP:0006554) | 1.66629340 |
| 169 | Renovascular hypertension (HP:0100817) | 1.65553010 |
| 170 | Absent speech (HP:0001344) | 1.64794772 |
| 171 | Annular pancreas (HP:0001734) | 1.64244910 |
| 172 | Intention tremor (HP:0002080) | 1.64054857 |
| 173 | Neoplasm of the oral cavity (HP:0100649) | 1.63377289 |
| 174 | Hyperventilation (HP:0002883) | 1.63104957 |
| 175 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.62991367 |
| 176 | Narrow nasal bridge (HP:0000446) | 1.62520413 |
| 177 | Thick eyebrow (HP:0000574) | 1.60986458 |
| 178 | Autism (HP:0000717) | 1.60717309 |
| 179 | Abnormality of the lower motor neuron (HP:0002366) | 1.60341078 |
| 180 | Attention deficit hyperactivity disorder (HP:0007018) | 1.59251230 |
| 181 | Sacral dimple (HP:0000960) | 1.57765989 |
| 182 | Dialeptic seizures (HP:0011146) | 1.57438922 |
| 183 | Vertebral arch anomaly (HP:0008438) | 1.57000127 |
| 184 | Broad palm (HP:0001169) | 1.56920316 |
| 185 | Abnormality of the nasal septum (HP:0000419) | 1.56680518 |
| 186 | Glioma (HP:0009733) | 1.55326022 |
| 187 | Oligodactyly (hands) (HP:0001180) | 1.55114231 |
| 188 | Hypoplasia of the maxilla (HP:0000327) | 1.55108043 |
| 189 | Dysmetria (HP:0001310) | 1.54824363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 3.37656654 |
| 2 | NTRK3 | 3.16626727 |
| 3 | TNIK | 2.99804417 |
| 4 | SIK2 | 2.87644010 |
| 5 | TYK2 | 2.34026642 |
| 6 | NTRK2 | 2.32958796 |
| 7 | BRD4 | 2.30924076 |
| 8 | MAP3K4 | 2.20885157 |
| 9 | CAMK1G | 2.19458207 |
| 10 | FGFR4 | 2.13034703 |
| 11 | EEF2K | 2.03357086 |
| 12 | TRIB3 | 1.91597952 |
| 13 | MAP3K14 | 1.90210497 |
| 14 | MAP3K13 | 1.83131746 |
| 15 | MAP3K9 | 1.78319835 |
| 16 | AKT3 | 1.76961383 |
| 17 | SGK2 | 1.76689255 |
| 18 | DAPK2 | 1.76114618 |
| 19 | BLK | 1.75735700 |
| 20 | BTK | 1.72207356 |
| 21 | SGK3 | 1.67523714 |
| 22 | KSR1 | 1.66881415 |
| 23 | BMPR2 | 1.63180768 |
| 24 | TXK | 1.59809234 |
| 25 | MAP3K7 | 1.58237263 |
| 26 | CAMK1D | 1.58012325 |
| 27 | FGFR2 | 1.57485312 |
| 28 | PRPF4B | 1.54198223 |
| 29 | PAK6 | 1.52753702 |
| 30 | NLK | 1.49953167 |
| 31 | MARK1 | 1.48957823 |
| 32 | TEC | 1.48950992 |
| 33 | TRPM7 | 1.44634607 |
| 34 | TAOK3 | 1.44033997 |
| 35 | RIPK4 | 1.43691132 |
| 36 | ZAP70 | 1.42876002 |
| 37 | MAP2K7 | 1.36421129 |
| 38 | MAP2K3 | 1.31369688 |
| 39 | MAP3K2 | 1.31226902 |
| 40 | IKBKE | 1.30699314 |
| 41 | FES | 1.27043137 |
| 42 | MAPK13 | 1.25940950 |
| 43 | MARK2 | 1.25557497 |
| 44 | SGK223 | 1.24832677 |
| 45 | SGK494 | 1.24832677 |
| 46 | CDK12 | 1.23581452 |
| 47 | IRAK4 | 1.19989738 |
| 48 | CDK19 | 1.18919167 |
| 49 | PRKCH | 1.18493506 |
| 50 | FRK | 1.18414822 |
| 51 | TYRO3 | 1.17017706 |
| 52 | CAMKK1 | 1.16776138 |
| 53 | RIPK1 | 1.15678379 |
| 54 | CDK6 | 1.12316142 |
| 55 | SIK3 | 1.11726033 |
| 56 | CAMK1 | 1.10853249 |
| 57 | CSK | 1.09672613 |
| 58 | MINK1 | 1.09072316 |
| 59 | KSR2 | 1.08784506 |
| 60 | PASK | 1.08186717 |
| 61 | STK38 | 1.03188497 |
| 62 | JAK2 | 1.03152470 |
| 63 | DYRK1A | 1.01703975 |
| 64 | MAPK11 | 1.01005202 |
| 65 | CDK5 | 0.99667592 |
| 66 | SMG1 | 0.99198150 |
| 67 | FGFR3 | 0.97894610 |
| 68 | WNK1 | 0.96068405 |
| 69 | SGK1 | 0.95203369 |
| 70 | CAMK4 | 0.94913846 |
| 71 | GRK6 | 0.93776274 |
| 72 | DAPK1 | 0.92864351 |
| 73 | SIK1 | 0.90485995 |
| 74 | CDC42BPA | 0.90285577 |
| 75 | ERBB3 | 0.89766606 |
| 76 | MAP2K4 | 0.89737878 |
| 77 | EPHA3 | 0.87630738 |
| 78 | EIF2AK3 | 0.86444589 |
| 79 | CDK4 | 0.83155541 |
| 80 | ERN1 | 0.82918972 |
| 81 | CAMKK2 | 0.82731657 |
| 82 | PNCK | 0.81653390 |
| 83 | MELK | 0.81387648 |
| 84 | MAP3K6 | 0.81049481 |
| 85 | KIT | 0.80924683 |
| 86 | YES1 | 0.79393542 |
| 87 | MAP4K1 | 0.77327016 |
| 88 | PIK3CG | 0.75331029 |
| 89 | EPHB1 | 0.75280116 |
| 90 | LYN | 0.73871557 |
| 91 | MAP3K10 | 0.73015958 |
| 92 | ICK | 0.71763047 |
| 93 | PHKG2 | 0.71273931 |
| 94 | PHKG1 | 0.71273931 |
| 95 | FGFR1 | 0.71125107 |
| 96 | HCK | 0.70016107 |
| 97 | IRAK1 | 0.69629858 |
| 98 | PDGFRB | 0.68788789 |
| 99 | CASK | 0.68712831 |
| 100 | RET | 0.67808989 |
| 101 | PDGFRA | 0.66894354 |
| 102 | CDK3 | 0.66409265 |
| 103 | TNK2 | 0.66381771 |
| 104 | CSNK1A1L | 0.66017154 |
| 105 | STK11 | 0.65893937 |
| 106 | JAK1 | 0.65443901 |
| 107 | RPS6KB2 | 0.64586035 |
| 108 | FYN | 0.62784179 |
| 109 | MAPK7 | 0.62394640 |
| 110 | UHMK1 | 0.61563884 |
| 111 | MAPK10 | 0.59728999 |
| 112 | MARK3 | 0.59678687 |
| 113 | RAF1 | 0.58032638 |
| 114 | MAPK12 | 0.56816159 |
| 115 | LMTK2 | 0.56416424 |
| 116 | PTK6 | 0.55356456 |
| 117 | RPS6KA3 | 0.55266125 |
| 118 | MAPK8 | 0.55170114 |
| 119 | TAOK2 | 0.54543323 |
| 120 | HIPK2 | 0.51702757 |
| 121 | TBK1 | 0.51205170 |
| 122 | MTOR | 0.50938851 |
| 123 | PRKD2 | 0.50932229 |
| 124 | NEK6 | 0.49459900 |
| 125 | JAK3 | 0.49414520 |
| 126 | PRKAA2 | 0.49334943 |
| 127 | CSNK1G2 | 0.48931942 |
| 128 | PDK1 | 0.48563954 |
| 129 | MKNK2 | 0.48263193 |
| 130 | PRKCQ | 0.47910841 |
| 131 | MAP3K1 | 0.47371817 |
| 132 | IKBKB | 0.47075876 |
| 133 | FGR | 0.46834367 |
| 134 | NEK9 | 0.46201285 |
| 135 | TTN | 0.45734409 |
| 136 | ALK | 0.45443042 |
| 137 | MAP2K6 | 0.44992147 |
| 138 | ITK | 0.44766025 |
| 139 | GSK3B | 0.43924225 |
| 140 | PRKCG | 0.43671089 |
| 141 | RPS6KA2 | 0.43467213 |
| 142 | SYK | 0.43453547 |
| 143 | ERBB2 | 0.42518663 |
| 144 | PRKD3 | 0.42494055 |
| 145 | PKN2 | 0.42417861 |
| 146 | LCK | 0.41441831 |
| 147 | CSF1R | 0.41051397 |
| 148 | TAOK1 | 0.40764394 |
| 149 | SRC | 0.40221113 |
| 150 | MAPK9 | 0.39605663 |
| 151 | DMPK | 0.39474839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.63642200 |
| 2 | Circadian entrainment_Homo sapiens_hsa04713 | 2.11092743 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.00642180 |
| 4 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.99844541 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 1.96748544 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 1.95574614 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.92164008 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 1.84294946 |
| 9 | Measles_Homo sapiens_hsa05162 | 1.71627883 |
| 10 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.67416692 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 1.67246121 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.61402044 |
| 13 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.60136513 |
| 14 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.51330038 |
| 15 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.51261765 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.51246434 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.47042333 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.46875392 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.45422410 |
| 20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.43594988 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.42874363 |
| 22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.42542523 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.42436409 |
| 24 | Hepatitis B_Homo sapiens_hsa05161 | 1.37973655 |
| 25 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.37220794 |
| 26 | Insulin secretion_Homo sapiens_hsa04911 | 1.35978042 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.35467732 |
| 28 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.34959513 |
| 29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.33760667 |
| 30 | Allograft rejection_Homo sapiens_hsa05330 | 1.33655562 |
| 31 | Long-term depression_Homo sapiens_hsa04730 | 1.28811633 |
| 32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.27109563 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.27037722 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.26712537 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26374720 |
| 36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.25408406 |
| 37 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.24838929 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.24358367 |
| 39 | Taste transduction_Homo sapiens_hsa04742 | 1.24120550 |
| 40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.22314797 |
| 41 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.22240640 |
| 42 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.19729627 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.19424229 |
| 44 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.19031609 |
| 45 | Cocaine addiction_Homo sapiens_hsa05030 | 1.18877263 |
| 46 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.17630796 |
| 47 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.17311240 |
| 48 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.16589951 |
| 49 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.15367433 |
| 50 | Prostate cancer_Homo sapiens_hsa05215 | 1.14398347 |
| 51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.13699485 |
| 52 | Glioma_Homo sapiens_hsa05214 | 1.12038522 |
| 53 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.11280844 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 1.09113384 |
| 55 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.08271069 |
| 56 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.07089813 |
| 57 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.06970755 |
| 58 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.06184214 |
| 59 | Tuberculosis_Homo sapiens_hsa05152 | 1.04058972 |
| 60 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.02720379 |
| 61 | Axon guidance_Homo sapiens_hsa04360 | 1.02689803 |
| 62 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.00063806 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.99494288 |
| 64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99212551 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.99172375 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.98689139 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.97810779 |
| 68 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.97593872 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96871870 |
| 70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.96627730 |
| 71 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.96080854 |
| 72 | Thyroid cancer_Homo sapiens_hsa05216 | 0.95657894 |
| 73 | Gap junction_Homo sapiens_hsa04540 | 0.95245654 |
| 74 | Endometrial cancer_Homo sapiens_hsa05213 | 0.94931421 |
| 75 | Colorectal cancer_Homo sapiens_hsa05210 | 0.94554918 |
| 76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.94514153 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.93276518 |
| 78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.92661687 |
| 79 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92497721 |
| 80 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.92248024 |
| 81 | * Insulin resistance_Homo sapiens_hsa04931 | 0.91604549 |
| 82 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90184074 |
| 83 | Circadian rhythm_Homo sapiens_hsa04710 | 0.90047770 |
| 84 | Melanogenesis_Homo sapiens_hsa04916 | 0.89562775 |
| 85 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.89559816 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.88618621 |
| 87 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.87654025 |
| 88 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.87503933 |
| 89 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.85657122 |
| 90 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.85356350 |
| 91 | Viral myocarditis_Homo sapiens_hsa05416 | 0.85209842 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84622866 |
| 93 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.82314712 |
| 94 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.81904415 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.81018054 |
| 96 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.80746756 |
| 97 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.80600160 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80235013 |
| 99 | * Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.80206630 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80165099 |
| 101 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.78745192 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78243892 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.77936526 |
| 104 | Platelet activation_Homo sapiens_hsa04611 | 0.77133392 |
| 105 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.76412578 |
| 106 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.75908181 |
| 107 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.75710943 |
| 108 | Apoptosis_Homo sapiens_hsa04210 | 0.73511305 |
| 109 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.73349923 |
| 110 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72662778 |
| 111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70993451 |
| 112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67958067 |
| 113 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.66395405 |
| 114 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66212334 |
| 115 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.64932714 |
| 116 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.64334690 |
| 117 | ABC transporters_Homo sapiens_hsa02010 | 0.64132709 |
| 118 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.63046710 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62454082 |
| 120 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60933003 |
| 121 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60105607 |
| 122 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60074384 |
| 123 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.59407733 |
| 124 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59083384 |
| 125 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58965204 |
| 126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58306306 |
| 127 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58086341 |
| 128 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57627997 |
| 129 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.56542696 |
| 130 | Asthma_Homo sapiens_hsa05310 | 0.55967822 |
| 131 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55816296 |
| 132 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55480679 |
| 133 | Adherens junction_Homo sapiens_hsa04520 | 0.55382812 |
| 134 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.55273584 |
| 135 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54548232 |
| 136 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54065482 |
| 137 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53813036 |
| 138 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.52650293 |
| 139 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52369748 |
| 140 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51351244 |
| 141 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.50572070 |
| 142 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.50367951 |
| 143 | Phototransduction_Homo sapiens_hsa04744 | 0.49942193 |
| 144 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49242401 |
| 145 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.42871026 |

